CAPOLLA, SARA

CAPOLLA, SARA  

Collaboratori  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autori File
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 1-gen-2015 MACOR, PAOLOMEZZAROBA, NELLYZORZET, SONIADURIGUTTO, PAOLOCAPOLLA, SARAMARZARI, ROBERTOTEDESCO, FRANCESCOSBLATTERO, DANIELE +
Complement as a biological tool to control tumor growth 1-gen-2018 Macor, PaoloCapolla, SaraTedesco, Francesco
Constitutive psgl-1 correlates with cd30 and tcr pathways and represents a potential target for immunotherapy in anaplastic large t-cell lymphoma 1-gen-2021 Balduit A.Capolla S.Ferrara I.Mangogna A. +
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 1-gen-2019 Grassi GabrielePozzato GabrieleSonia ZorzetSara CapollaMacor PaoloBruna ScaggianteChiara GuerraChiara GnanFabrizio ZanconatiDapas Barbara +
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target 1-gen-2020 Capolla S.Di Cintio F.Toffoli G.Macor P. +
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 1-gen-2020 Dapas B.Pozzato G.Zorzet S.Capolla S.Macor P.Scaggiante B.Guerra C.Gnan C.Zanconati F.Grassi G. +
Nanoparticles-based oligonucleotides delivery in cancer: Role of zebrafish as animal model 1-gen-2021 Bozzer S.Toffoli G.Macor P.Capolla S. +
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 1-gen-2015 CAPOLLA, SARAMEZZAROBA, NELLYZORZET, SONIAGRANZOTTO, MARILENAVITA, FRANCESCAPOZZATO, GABRIELEMACOR, PAOLO +
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 1-gen-2013 MEZZAROBA, NELLYZORZET, SONIACAPOLLA, SARALUCAFO, MARIANNABAJ, GabrielePOZZATO, GABRIELEMACOR, PAOLO +
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. 1-gen-2014 DEREANI, SARAMACOR, PAOLOD'AGARO, TIZIANAMEZZAROBA, NELLYCAPOLLA, SARAZUCCHETTO, ANTONELLAZORZET, SONIABOMBEN, RICCARDO +
Targeted nanoparticles and complement activation 1-gen-2017 MACOR, PAOLOCAPOLLA, SARACOLOMBO, FEDERICODE MASO, LucaDURIGUTTO, PAOLOTEDESCO, FRANCESCOMACOR, PAOLO
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 1-gen-2015 CAPOLLA, SARAGARROVO, CHIARAZORZET, SONIAPOZZATO, GABRIELEMACOR, PAOLOBIFFI, STEFANIA +